In a groundbreaking move, the Indian pharmaceutical industry is revolutionizing its manufacturing processes by adopting automation and the Industrial Internet of Things (IIoT) to ensure unparalleled quality control and regulatory compliance. By seamlessly integrating IIoT sensors and automated systems throughout production and distribution, pharmaceutical companies are achieving real-time monitoring of crucial parameters, ensuring consistency and […]
Category: pharma market trends
Astellas Pharma Employee Sentenced for Espionage in China: A Look at the Controversial Case
Recently, a Japanese employee of Astellas Pharma was sentenced to three years and six months in prison for espionage in China. Despite the ruling, the employee chose not to appeal by the deadline. The incident dates back to March 2023 when the employee was detained by Chinese authorities just before returning to Japan. He was […]
Dr. Reddy’s Laboratories Invests Significantly in Russian Subsidiary, Strengthening Global Presence
Dr. Reddy’s Laboratories Ltd., a renowned global pharmaceutical company based in Hyderabad, India, continues to make strategic investments to enhance its presence in key markets. Recently, the company announced a substantial investment of Rs 565.4 crore in its subsidiary, Dr. Reddy’s Laboratories LLC, Russia (DRL Russia), thereby acquiring a 45.19% equity stake in the entity. […]
Torrent Pharmaceuticals Prepares for Semaglutide Launch in 2026 After Patent Expiry
Torrent Pharmaceuticals is gearing up to release both oral and injectable versions of Semaglutide, a popular diabetes and weight loss drug, after the patent expires in early 2026. The company plans to produce the active pharmaceutical ingredient (API) in-house at its manufacturing plant in Gujarat’s Dahej while potentially outsourcing some parts of the formulation process […]
MIRA Pharmaceuticals Receives FDA Approval for Ketamir-2, Paving the Way for U.S. Clinical Trials in Neuropathic Pain
MIRA Pharmaceuticals, a pioneering clinical-stage pharmaceutical company specializing in treatments for neurologic, neuropsychiatric, and metabolic disorders, has achieved a major milestone with the clearance of its Investigational New Drug (IND) application for Ketamir-2 by the U.S. Food and Drug Administration (FDA). This groundbreaking oral NMDA receptor antagonist shows significant promise for alleviating neuropathic pain, marking […]